Tucked away among dozens of projects proposed for the next county bond election are a couple that could restore the seasonal flow of water in the Pantano Wash through Vail. One $4 million project ...

Almirall SA (GB:0O9B) announced an update on their ongoing clinical study. Study Overview: Almirall S.A. is running a phase 2 trial called “A Phase 2, Randomized, Placebo-controlled, Double-blind ...

Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline Paris, December 24, 2025. Sanofi announced today that it has entered into an ...

EMERYVILLE, Calif., Dec. 24, 2025 /PRNewswire/ -- Sanofi announced today that it has entered into an agreement to acquire Dynavax Technologies Corporation (Nasdaq: DVAX), a publicly traded vaccines ...

"Dynavax enhances Sanofi's adult immunization presence by adding differentiated vaccines that complement Sanofi's expertise," said Thomas Triomphe, Executive Vice President, Vaccines, Sanofi. "Its ...

SHENZHEN, China—DJI today unveiled the Osmo Action 6, an all-in-one action camera featuring a variable aperture with a range from f/2.0 to f/4.0, the company’s custom 1/1.1-inch square CMOS sensor and ...

The "Breast Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering. The ...

With federal subsidies ending or becoming hard to claim, companies are racing ahead with solar, wind and battery projects. By Rebecca F. Elliott President Trump is poised to preside over a renewable ...

Genmab (GMAB) announced this morning it will acquire Merus (MRUS) for $97 per share in an all-cash deal valued at about $8.0 bln, bringing Merus's late-stage oncology asset petosemtamab into GMAB's ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Bacteriophages offer a promising alternative to conventional antimicrobials, ...